Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- CheckyesterdayChange DetectedThe page shows a minor site revision update: an addition of Revision: v3.3.4 and removal of Revision: v3.3.3; these changes do not affect the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedExpanded and updated the Locations section with entries across multiple regions (US states, Alberta, Ontario, Gyeong Gi-do) and added Revision: v3.3.3. Older location blocks were removed.SummaryDifference1%

- Check51 days agoChange DetectedPubMed-based publication notes were updated to state that publications are automatically filled from PubMed and to include a new revision label (v3.3.2). The earlier PubMed note and revision label (v3.2.0) were removed.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the government funding status notice; the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check80 days agoChange DetectedNo significant changes observed between the old and new VOYAGER study pages for NCT03465722.SummaryDifference0.2%

- Check102 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.